Caris Life Sciences Inc. (CAI) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Caris Life Sciences Inc.

    NASDAQ: CAI · Real-Time Price · USD
    31.78
    2.07 (6.97%)
    At close: Oct 03, 2025, 3:59 PM
    31.74
    -0.13%
    After-hours: Oct 03, 2025, 07:51 PM EDT

    Caris Life Sciences Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Net Income
    		 -281.89M -341.42M -320.83M
    Depreciation & Amortization
    		 48.91M 49M 48.25M
    Stock-Based Compensation
    		 18.64M 15.24M 22.9M
    Other Working Capital
    		 -484K 5.22M -8.16M
    Other Non-Cash Items
    		 -1.8M 8.2M -13.78M
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 -29.07M -7.13M -22.26M
    Operating Cash Flow
    		 -245.2M -276.1M -285.71M
    Capital Expenditures
    		 -8.44M -22.32M -42.26M
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 n/a -63.4M -378.38M
    Sales Maturities Of Investments
    		 61.38M 300.49M 137.65M
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 52.93M 214.77M -282.99M
    Debt Repayment
    		 199.82M 10.57M -962K
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 471K -435K 11.41M
    Financial Cash Flow
    		 200.29M 10.13M 10.45M
    Net Cash Flow
    		 8.02M -51.13M -558.25M
    Free Cash Flow
    		 -253.64M -298.42M -327.96M

    Add to Watchlist